Printer Friendly
The Free Library
14,678,926 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

InforSense and Tripos Announce Alliance to Improve Drug Discovery Decision-Making.


ST. LOUIS & LONDON & CAMBRIDGE, Mass. -- Tripos, Inc. (Nasdaq:TRPS TRPS Trigger Point (myofacial pain)
TRPS TrichoRhinoPhalangeal Syndrome
TRPS Temperature Regulating Power Supply
TRPS Time Reporting and Payroll System
) and InforSense:

--Tripos joins InforSense Open Workflow Partner Network

--InforSense joins Tripos Alliance Program

--Companies Working Towards Technology Integration

Tripos, Inc. and InforSense today announced an alliance to integrate Tripos' discovery informatics portfolio with the award-winning InforSense KDE (K Desktop Environment) A GUI-based user interface primarily for Unix and Linux machines, but also available for Windows and Mac. The source code is freely distributed and is maintained by developers around the world.  workflow-based integrative analytics platform. Through the alliance, Tripos joins InforSense's Open Workflow Partner Network (OWPN) and InforSense joins Tripos' Alliance Program as a Software Partner. The two companies will also integrate Tripos' AUSPYX, SYBYL and UNITY technologies with both InforSense KDE and its 'in Oracle' enterprise analytics system, InforSense IOE IOE Institute of Education (UK)
IOE International Organisation of Employers (Geneva, Switzerland)
IOE Industrial and Operations Engineering
IoE Institute of the Environment (UCLA) 
. This integration enables customers such as Bayer Healthcare who are using technology from both companies, to access and integrate Tripos' discovery informatics technologies within InforSense KDE, thus streamlining complex discovery processes to deliver more efficient decision-making and improved productivity.

"We are excited to work with InforSense to benefit our joint customers," said Bryan Koontz, senior vice president and general manager of Discovery Informatics at Tripos. "The integrated Tripos-InforSense solution offers a powerful and flexible informatics platform for rapid application development and deployment, and takes advantage of our standardization on web services (1) Loosely, any online service delivered over the Web. Such usage appears in articles from non-technical sources, but not in IT-oriented publications, because definition #2 below describes the correct use of the term.  and related Service-Oriented Informatics (SOI (Silicon On Insulator) A chip architecture that increases transistor switching speed by reducing capacitance (build-up of electrical charges in the transistor's elements), and thus reducing the discharge time. The power requirement is also reduced in some designs. ) technologies. The technical alliance between Tripos and InforSense is a successful example of this strategy, providing mutual customers with even more options for deploying innovative science and discovery software in an open workflow environment."

"Our customers require seamless interoperability between their choice of data resources, analytic tools and services," commented Joseph F. Donahue, Chief Business Officer of InforSense. "By combining the workflow technology Workflow technology is a new field of software products designed to improve the design of information systems. It involves use of workflow engine to execute models of processes. The models can be edited by persons not experienced in programming (e.g.  of InforSense KDE with Tripos' innovative discovery informatics portfolio, we can provide our joint customers with a flexible and easy to use environment for their chemistry research that is able to integrate data and computing resources across the entire R&D organization."

About Tripos

Tripos (Nasdaq:TRPS) combines leading-edge technology and innovative science to deliver consistently superior chemistry-research products and services for the biotechnology, pharmaceutical and other life science industries. Within Tripos' Discovery Informatics (DI) business, the company provides software products and consulting services to develop, manage, analyze and share critical drug discovery information. Within Tripos' Discovery Research (DR) business, Tripos' medicinal chemists and research scientists partner directly with clients in their research initiatives, leveraging state-of-the-art information technologies and research facilities. Headquartered in St. Louis, Mo., Tripos spans the world with global research operations and an international client base. Further information on Tripos can be found at www.tripos.com.

Tripos and the Tripos logo are registered trademarks of Tripos, Inc., and/or its affiliates in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and certain other countries. All other trademarks mentioned in this document are the property of their respective owners.

This press release contains forward-looking statements concerning expectations regarding the benefits that may be realized by Tripos resulting from its alliance with InforSense. These statements are based upon numerous assumptions which Tripos cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including, without limitations, those factors set forth in the Company's Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the fiscal year ended December 31, 2004, and from time to time in the Company's periodic filings with the Securities and Exchange Commission. Except as otherwise required under federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise.

About InforSense

InforSense Limited, the leader in integrative analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes Presented below is a list of topics on decision-making and decision-making processes:

| width="" align="left" valign="top" |
  • Choice
  • Cybernetics
  • Decision
  • Decision making
  • Decision theory


| width="" align="left" valign="top" |
. Leading pharmaceutical and biotechnology, consumer goods consumer goods

Any tangible commodity purchased by households to satisfy their wants and needs. Consumer goods may be durable or nondurable. Durable goods (e.g., autos, furniture, and appliances) have a significant life span, often defined as three years or more, and
, financial services The examples and perspective in this article or section may not represent a worldwide view of the subject.
Please [ improve this article] or discuss the issue on the talk page.
 companies, and research institutes are using the company's flagship product, InforSense KDE, to enhance productivity across life science R&D, healthcare and business analytics. The company is privately held, with European headquarters in London, UK and North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 headquarters in Cambridge, Massachusetts.

About InforSense KDE

Using InforSense KDE, enterprises rapidly integrate and deliver virtually any data source, analytic software tool, service or application within a single informatics framework. Users link these components via visual workflows to dynamically answer any question using their data, however complex or transient. Organizations can also mine their analytical processes to discover and deploy expertise and best practices. InforSense KDE provides an open, extensible service-oriented architecture, built using industry standards including J2EE (Java 2 Platform, Enterprise Edition) A platform from Sun for building distributed enterprise applications. J2EE services are performed in the middle tier between the user's machine and the enterprise's databases and legacy information systems. , XML XML
 in full Extensible Markup Language.

Markup language developed to be a simplified and more structural version of SGML. It incorporates features of HTML (e.g., hypertext linking), but is designed to overcome some of HTML's limitations.
, and WSDL (Web Services Description Language) An XML-based language for defining Web services. Developed by Microsoft and IBM, WSDL describes the protocols and formats used by the service. . InforSense IOE is a state-of-the-art solution for enterprise wide integrative analytics using Oracle's advanced information management and processing capabilities. For further information on InforSense products and solutions, visit www.inforsense.com.

InforSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 12, 2005
Words:798
Previous Article:New Research Indicates that Women Are Now the Leading Internet Shoppers, In Terms of both Volume and Value.
Next Article:Dacogen(TM) (Decitabine) Injection Data Presented at American Society of Hematology (ASH) Annual Meeting; Updated Data From Alternative Dosing...
Topics:



Related Articles
Tripos and ONYX announce joint agreement for new high throughput screening software.
TRIPOS EXPANDS PLATFORMS FOR SYBYL DISCOVERY SOFTWARE TO INCLUDE HP WORKSTATIONS & SERVERS.(Brief Article)(Product Announcement)
Spotfire and Tripos Partner to Deliver Fully-Integrated Data Management and Analysis Solution.
LION Bioscience Announces Sale of its Shareholdings in Tripos Inc.; No Strategic Need for Tripos Shareholding After Successful Completion of...
Signase Announces Second Round of Financing.
Ionix and Tripos Collaborate On Discovery of Novel Analgesics.
InforSense and Tripos Announce Alliance to Improve Drug Discovery Decision-Making.
InforSense KDE 3.0 Released: Enabling Decision-Making Enterprise-Wide.
Tripos Reports Fourth-Quarter and Full-Year 2005 Financial Results.
Tripos Announces New Software for Automatic Flexible Molecular Alignment.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles